0A55 logo

QuidelOrtho LSE:0A55 Stock Report

Last Price

US$47.05

Market Cap

US$3.1b

7D

-3.0%

1Y

-44.6%

Updated

24 Mar, 2024

Data

Company Financials +

QuidelOrtho Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for QuidelOrtho
Historical stock prices
Current Share PriceUS$47.05
52 Week HighUS$96.85
52 Week LowUS$41.71
Beta0.11
1 Month Change-0.39%
3 Month Change-37.29%
1 Year Change-44.62%
3 Year Changen/a
5 Year Changen/a
Change since IPO-50.74%

Recent News & Updates

Recent updates

Shareholder Returns

0A55GB Medical EquipmentGB Market
7D-3.0%-1.3%2.3%
1Y-44.6%2.8%4.9%

Return vs Industry: 0A55 underperformed the UK Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: 0A55 underperformed the UK Market which returned 4.9% over the past year.

Price Volatility

Is 0A55's price volatile compared to industry and market?
0A55 volatility
0A55 Average Weekly Movement11.1%
Medical Equipment Industry Average Movement7.6%
Market Average Movement4.7%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0A55's share price has been volatile over the past 3 months.

Volatility Over Time: 0A55's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
19797,100Mike Iskrahttps://www.quidelortho.com

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

QuidelOrtho Corporation Fundamentals Summary

How do QuidelOrtho's earnings and revenue compare to its market cap?
0A55 fundamental statistics
Market capUS$3.13b
Earnings (TTM)-US$10.10m
Revenue (TTM)US$3.00b

1.0x

P/S Ratio

-309.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0A55 income statement (TTM)
RevenueUS$3.00b
Cost of RevenueUS$1.50b
Gross ProfitUS$1.49b
Other ExpensesUS$1.50b
Earnings-US$10.10m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin49.85%
Net Profit Margin-0.34%
Debt/Equity Ratio48.4%

How did 0A55 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.